JR, B., S, B., C, D., KJ, E., PM, F., C, G., . . . AJ, P. (2021). Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nature medicine, 27(6), 1113. https://doi.org/10.1038/s41591-021-01372-z
Chicago Style (17th ed.) CitationJR, Barrett, et al. "Author Correction: Phase 1/2 Trial of SARS-CoV-2 Vaccine ChAdOx1 NCoV-19 with a Booster Dose Induces Multifunctional Antibody Responses." Nature Medicine 27, no. 6 (2021): 1113. https://doi.org/10.1038/s41591-021-01372-z.
MLA (9th ed.) CitationJR, Barrett, et al. "Author Correction: Phase 1/2 Trial of SARS-CoV-2 Vaccine ChAdOx1 NCoV-19 with a Booster Dose Induces Multifunctional Antibody Responses." Nature Medicine, vol. 27, no. 6, 2021, p. 1113, https://doi.org/10.1038/s41591-021-01372-z.